US$ 23.17
bpc-157 clinical study humans The Real Story: 544 Papers, 30 Human Subjects, 50 Million Views Regeneration or Risk? A Narrative
Description
A nice double-blind study from 2009 showed that 5% SAP reduced the inflammatory lesions by 20.14% and 48.82% within 4 and 8 weeks respectively and when combined with 0.2% retinol the results were even better

BPC-157 has the most comprehensive preclinical evidence base for tendon-to-bone healing, fibroblast migration, and Achilles models

Individual circumstances: While guidelines are in place, a doctor is ultimately responsible for making decisions appropriate for each patient

General tissue health optimization